Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
…, G Ruiz‐Irastorza, MA Khamashta… - Arthritis & …, 2012 - Wiley Online Library
Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…
[PDF][PDF] International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop
…, GRV Hughes, DA Triplett, MA Khamashta - … : Official Journal of the …, 1999 - researchgate.net
Preliminary classification criteria for the antiphospholipid syndrome (APS) were formulated
during a post-conference workshop held October 10, 1998 in Sapporo, Japan, following the …
during a post-conference workshop held October 10, 1998 in Sapporo, Japan, following the …
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
…, JC Piette, J Font, MA Khamashta… - … : Official Journal of …, 2002 - Wiley Online Library
Objective To analyze the clinical and immunologic manifestations of antiphospholipid
syndrome (APS) in a large cohort of patients and to define patterns of disease expression. …
syndrome (APS) in a large cohort of patients and to define patterns of disease expression. …
[HTML][HTML] The management of thrombosis in the antiphospholipid-antibody syndrome
MA Khamashta, MJ Cuadrado, F Mujic… - … England Journal of …, 1995 - Mass Medical Soc
Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. …
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. …
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
The “primary” antiphospholipid syndrome: major clinical and serological features
RA ASHERSON, MA KHAMASHTA, J Ordi-Ros… - Medicine, 1989 - journals.lww.com
ASHERSON, RONALD AMD, FACP, FCP,(SA) 1; KHAMASHTA, MUNTHER AMD 1; ORDI-ROS,
JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …
JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD SEBASTIANI… - Medicine, 1993 - journals.lww.com
Systemic Lupus Erythematosus: Clinical and Immunologic Patte... : Medicine Systemic Lupus
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Immune-related adverse events of checkpoint inhibitors
…, A Flores-Chávez, N Keegan, MA Khamashta… - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Adult haemophagocytic syndrome
…, P Brito-Zerón, A López-Guillermo, MA Khamashta… - The Lancet, 2014 - thelancet.com
Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of
causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ …
causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ …
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
…, P Brito-Zeron, MA Khamashta - Annals of the …, 2010 - ard.bmj.com
Background: Antimalarial drugs (AMs), chloroquine (CQ) and hydroxychloroquine (HCQ), are
frequently withdrawn in patients with lupus with either severe or remitting disease. However…
frequently withdrawn in patients with lupus with either severe or remitting disease. However…